Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 274 followers

Latest posts

Last updated about 7 hours ago

Periodic safety update reports (PSURs)

about 7 hours ago

Periodic safety update reports (PSURs)

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

about 7 hours ago

List of European Union reference dates (EURD) and frequency of submission of...

Herbal medicinal product: Uvae ursi folium, Arctostaphylos uva-ursi (L.) Spreng., C: ongoing call for scientific data

about 8 hours ago

Herbal medicinal product: Uvae ursi folium, Arctostaphylos uva-ursi (L.) Spreng., C: ongoing...

Herbal medicinal product: Meliloti herba, Melilotus officinalis (L.) Lam., C: ongoing call for scientific data

about 8 hours ago

Herbal medicinal product: Meliloti herba, Melilotus officinalis (L.) Lam., C: ongoing call...

Herbal medicinal product: Lupuli flos, Humulus lupulus L., C: ongoing call for scientific data

about 8 hours ago

Herbal medicinal product: Lupuli flos, Humulus lupulus L., C: ongoing call for...

Herbal medicinal product: Cisti cretici herba, Cistus creticus L., D: Draft under discussion

about 8 hours ago

Herbal medicinal product: Cisti cretici herba, Cistus creticus L., D: Draft under...

Herbal medicinal product: Gentianae radix, Gentiana lutea L., C: ongoing call for scientific data

about 8 hours ago

Herbal medicinal product: Gentianae radix, Gentiana lutea L., C: ongoing call for...

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of authorisation: 03/10/2011, Revision: 19, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of...

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 42, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation...

Draft ICH Q1 guideline on stability testing of drug substances and drug products - Step 2b

about 9 hours ago

Draft ICH Q1 guideline on stability testing of drug substances and drug...

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted),selvacovatein,damlecovatein, Date of authorisation: 30/03/2023, Revision: 9, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted),selvacovatein,damlecovatein...